Oklo (NYSE:OKLO) Shares Down 6.2% Following Weak Earnings

Oklo Inc. (NYSE:OKLO)’s stock price was down 6.2% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $56.68 and last traded at $56.7510. Approximately 11,811,851 shares changed hands during trading, an increase of 10% from the average daily volume of 10,699,205 shares. The stock had previously closed at $60.53.

The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.10). During the same quarter in the previous year, the company earned ($0.74) EPS.

Oklo News Roundup

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Oklo secured multiple federal approvals that materially de‑risk commercialization pathways — including DOE Nuclear Safety Design Agreement(s) tied to its Aurora reactor and Groves isotopes test reactor, which accelerate project execution and isotope production potential. BusinessWire: DOE NSDA approval
• Positive Sentiment: Oklo’s Atomic Alchemy unit won a first-of-its-kind NRC materials license for isotope work — opening an early revenue channel (isotope processing/supply) that shortens the timeline to meaningful commercial receipts versus waiting for full reactor deployments. Yahoo: NRC license for Atomic Alchemy
• Neutral Sentiment: High‑profile media exposure — including a CNBC interview with CEO Jacob DeWitte — is increasing investor awareness and liquidity but is not by itself a fundamental catalyst. CNBC CEO interview
• Neutral Sentiment: Strategic partnerships (Meta power‑campus plans, talks with Centrus on HALEU fuel services) underpin the long‑term growth story but remain execution‑dependent and will take quarters to materially affect revenue. Yahoo: Meta deal & valuation check
• Negative Sentiment: Q4 earnings missed expectations — Oklo reported EPS of ($0.27) vs. consensus ($0.17) and remains pre‑revenue; the miss raises short‑term scrutiny on cash burn and timing of commercial revenue. ProactiveInvestors: Q4 results
• Negative Sentiment: Several sell‑side firms trimmed price targets this morning (Goldman Sachs to $65 neutral; Citigroup to $73.50 neutral; Needham, others lowered targets), increasing downward pressure despite some remaining buy ratings. Many of the revisions were published via Benzinga/TickerReport. Benzinga: analyst target moves
• Negative Sentiment: Insider selling from senior executives (CEO and CFO sold sizable blocks in mid‑March) is attracting negative attention and likely added supply into the market today, compounding selling from analyst cuts. Blockonomi: insiders offload

Wall Street Analyst Weigh In

Several research firms have recently issued reports on OKLO. Zacks Research lowered Oklo from a “hold” rating to a “strong sell” rating in a report on Friday, January 23rd. Citigroup decreased their target price on shares of Oklo from $95.00 to $73.50 and set a “neutral” rating on the stock in a report on Wednesday. Bank of America upgraded shares of Oklo from a “neutral” rating to a “buy” rating and boosted their target price for the company from $111.00 to $127.00 in a research report on Wednesday, January 21st. Barclays reduced their price target on shares of Oklo from $146.00 to $82.00 and set an “overweight” rating on the stock in a research report on Monday, February 23rd. Finally, The Goldman Sachs Group lowered their price objective on shares of Oklo from $91.00 to $65.00 and set a “neutral” rating for the company in a research report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $86.63.

Insiders Place Their Bets

In other news, insider William Carroll Murphy Goodwin sold 2,820 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $56.69, for a total transaction of $159,865.80. Following the completion of the transaction, the insider directly owned 15,991 shares in the company, valued at approximately $906,529.79. This represents a 14.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Richard Craig Bealmear sold 72,090 shares of the firm’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $60.00, for a total value of $4,325,400.00. Following the sale, the chief financial officer directly owned 386,008 shares in the company, valued at approximately $23,160,480. This trade represents a 15.74% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 2,062,424 shares of company stock valued at $169,888,312. 18.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Oklo

Several institutional investors and hedge funds have recently made changes to their positions in OKLO. Royal Bank of Canada lifted its position in shares of Oklo by 162.6% in the 1st quarter. Royal Bank of Canada now owns 92,850 shares of the company’s stock worth $2,009,000 after purchasing an additional 57,497 shares during the period. AQR Capital Management LLC bought a new position in shares of Oklo in the 1st quarter worth about $519,000. Millennium Management LLC lifted its stake in shares of Oklo by 4,974.1% in the 1st quarter. Millennium Management LLC now owns 582,002 shares of the company’s stock valued at $12,589,000 after purchasing an additional 570,532 shares during the period. NewEdge Advisors LLC lifted its stake in shares of Oklo by 165.6% in the 1st quarter. NewEdge Advisors LLC now owns 15,672 shares of the company’s stock valued at $339,000 after purchasing an additional 9,772 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Oklo by 90.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 112,772 shares of the company’s stock valued at $2,439,000 after purchasing an additional 53,703 shares in the last quarter. Institutional investors and hedge funds own 85.03% of the company’s stock.

Oklo Stock Down 6.2%

The firm has a market cap of $8.87 billion, a price-to-earnings ratio of -78.82 and a beta of 0.80. The firm has a 50 day moving average of $74.26 and a 200 day moving average of $95.00.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.